Aclaris Therapeutics, Inc. (ACRS) vs Altimmune, Inc. (ALT)
A side-by-side comparison of Aclaris Therapeutics, Inc. and Altimmune, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACRS
Aclaris Therapeutics, Inc.
$3.68HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
ALT
Altimmune, Inc.
$2.66HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — ACRS vs ALT
growth of $100 · dividends reinvested · last 9yACRS -82.9% (-17.8%/yr)ALT -98.0% (-35.2%/yr)ACRS compounded faster over this window
Log scale — wide-divergence pair
ACRS ALT
ACRS vs ALT: by the numbers
- •ALT is the larger company ($517M vs $514M market cap).
- •Both run net losses; ACRS's is the smaller (-921.50% vs -296000.00% net margin).
- •ACRS grew revenue faster over the past five years (4.39% vs -65.38% CAGR).
Metrics side by side
Valuation
| Metric | ACRS | ALT |
|---|---|---|
| P/S ratio | 62.51 | 16674.58 |
| P/B ratio | 4.12 | 1.09 |
Profitability
| Metric | ACRS | ALT |
|---|---|---|
| Gross margin | 73.28% | 100.00% |
| Operating margin | -975.91% | -230460.98% |
| Net margin | -921.50% | -296000.00% |
| ROE | -60.79% | -19.35% |
| ROIC | -56.99% | -19.47% |
Growth (annualized)
| Metric | ACRS | ALT |
|---|---|---|
| Revenue CAGR (5Y) | 4.39% | -65.38% |
| Total return CAGR (5Y) | -24.23% | -25.30% |
Frequently asked
- Which has grown faster, ACRS or ALT?
- Over the past five years, ACRS grew revenue faster — ACRS at a 4.39% CAGR versus ALT at -65.38%.
- How have ACRS and ALT total returns compared?
- Over the past 5 years, ACRS delivered -24.23% and ALT delivered -25.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.